 |
|
Role of Sleep Duration and Quality in the Risk and Severity of Type 2 Diabetes Mellitus
Kristen L. Knutson, PhD;
Armand M. Ryden, MD;
Bryce A. Mander, BA;
Eve Van Cauter, PhD
Arch Intern Med. 2006;166:1768-1774.
Background Evidence from laboratory and epidemiologic studies suggests that decreased sleep duration or quality may increase diabetes risk. We examined whether short or poor sleep is associated with glycemic control in African Americans with type 2 diabetes mellitus.
Methods We conducted a cross-sectional study of volunteers with type 2 diabetes interviewed at the University of Chicago Hospitals, Chicago, Ill. The final analysis included 161 participants. Glycemic control was assessed by hemoglobin A1c (HbA1c) level obtained from medical charts. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Perceived sleep debt was calculated as the difference between preferred and actual weekday sleep duration.
Results The mean ± SD sleep duration was 6.0 ± 1.6 hours, and 71% of the participants were classified as having poor quality sleep (PSQI score >5). We excluded patients with sleep frequently disrupted by pain (n = 39). In patients without diabetic complications, glycemic control was associated with perceived sleep debt but not PSQI score. The predicted increase in HbA1c level for a perceived sleep debt of 3 hours per night was 1.1% above the median. In patients with at least 1 complication, HbA1c level was associated with PSQI score but not perceived sleep debt. The predicted increase in HbA1c level for a 5-point increase in PSQI was 1.9% above the median.
Conclusions In our sample, sleep duration and quality were significant predictors of HbA1c, a key marker of glycemic control. Combined with existing evidence linking sleep loss to increased diabetes risk, these data suggest that optimizing sleep duration and quality should be tested as an intervention to improve glucose control in patients with type 2 diabetes.
Author Affiliations: Department of Medicine, University of Chicago (Drs Knutson, Ryden, and Van Cauter, and Mr Mander); and Institute for Neuroscience, Northwestern University (Mr Mander); Chicago, Ill.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography
Parker et al.
JCO 2008;26:2464-2472.
ABSTRACT
| FULL TEXT
Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation
Tasali and Ip
Proc Am Thorac Soc 2008;5:207-217.
ABSTRACT
| FULL TEXT
Obstructive Sleep Apnea and Type 2 Diabetes: Interacting Epidemics
Tasali et al.
Chest 2008;133:496-506.
ABSTRACT
| FULL TEXT
Cross-sectional versus Prospective Associations of Sleep Duration with Changes in Relative Weight and Body Fat Distribution: The Whitehall II Study
Stranges et al.
Am J Epidemiol 2008;167:321-329.
ABSTRACT
| FULL TEXT
Slow-wave sleep and the risk of type 2 diabetes in humans
Tasali et al.
Proc. Natl. Acad. Sci. USA 2008;105:1044-1049.
ABSTRACT
| FULL TEXT
Do Childhood Sleeping Problems Predict Obesity in Young Adulthood? Evidence from a Prospective Birth Cohort Study
Mamun et al.
Am J Epidemiol 2007;166:1368-1373.
ABSTRACT
| FULL TEXT
The Insidious Effects of Lost Sleep
DOC News 2007;4:4-4.
FULL TEXT
C-reactive protein Levels and Sleep Disturbances: Observations Based on The Northern Finland 1966 Birth Cohort Study
Liukkonen et al.
Psychosom. Med. 2007;69:756-761.
ABSTRACT
| FULL TEXT
Sleep Disturbances Increase Interleukin-6 Production During Pregnancy: Implications for Pregnancy Complications
Okun et al.
Reproductive Sciences 2007;14:560-567.
ABSTRACT
Sleep and health: everywhere and in both directions.
Zee and Turek
Arch Intern Med 2006;166:1686-1688.
FULL TEXT
|
